As the major research partner of Eli Lilly & Company in China, ChemExplorer synthesizes organic compounds in various quantities with diversified chemical platforms for novel pharmaceuticals research and development after a long-term collaboration contract was signed in 2002. This has allowed it to grow as a world class R & D enterprise under the guidance of one of the largest Pharmaceutical Company in the world. In turn, it provides a platform for which China can enter into the Global Pharmaceutical R & D stage.
ChemExplorer was found in June of 2002, locates in the most prominent life science research and development center in China - Zhangjiang Hi-Tech Pack in Pudoung New Area of Shanghai.
It designs its facilities using internationally accepted criteria and makes every effort to meet the challenge of providing a safe, practical, and environmental pleasing workplace for its employees. It has in its facilities state-of-the-arts instruments such as NMR (300 mHz), LC/MS (Agilent), GC/MS(Agilent), high-resolution MS, various analytical and preparation HPLC (Gilson and Shimadzu).
In the fourth year of its existence, ChemExplorer has a R&D team of over 250 research scientists; 20% of whom have a Doctoral degree, and more than 40% of them have a Master degree.
ShangPharma, the holding company of Shanghai ChemPartner Co Ltd and Shanghai ChemExplorer Co Ltd, is one of the largest CROs providing a comprehensive portfolio of services to global pharmaceutical and biotech companies. It has a team of skilled scientists and a problem-solving culture that enable us to respond to pharmaceutical and biotechnology clients' toughest challenges.
ShangPharma, based in Zhangjiang Hi-Tech Park, Pudong, Shanghai, currently has a staff of more than 1,500 scientists in virtually all disciplines. Among them, more than 62% of the scientific staff have post-graduate degrees. All of the key scientific leaders have western educational backgrounds coupled with extensive R&D experience in major pharmaceutical and biotechnology companies.